Noroxin and Hepatocellular damage - a phase IV clinical study of FDA data

Summary:

Hepatocellular damage is reported as a side effect among people who take Noroxin (norfloxacin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nexium, and have Suicide attempt.

The phase IV clinical study analyzes which people have Hepatocellular damage when taking Noroxin. It is created by eHealthMe based on reports of 1,655 people who have side effects when taking Noroxin from the FDA, and is updated regularly.

What is Noroxin?

Noroxin has active ingredients of norfloxacin. It is often used in urinary tract infection. eHealthMe is studying from 1,675 Noroxin users. Check the latest studies of Noroxin.

What is Hepatocellular damage?

Hepatocellular damage (liver damage) is found to be associated with 503 drugs and 610 conditions by eHealthMe. Check the latest studies of Hepatocellular damage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,655 people reported to have side effects when taking Noroxin.
Among them, 20 people (1.21%) have Hepatocellular damage.

Could Noroxin cause Hepatocellular damage?

Among these 20 people:

How long have people been on Noroxin when they have Hepatocellular damage? *

What is the gender of people who have Hepatocellular damage when taking Noroxin? *

female: 60 %
male: 40 %

What is the age of people who have Hepatocellular damage when taking Noroxin? *

What are other drugs people take besides Noroxin? *

What are other side effects people have besides Hepatocellular damage? *

Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 5 people, 25.00%
Acute Kidney Failure: 2 people, 10.00%
Aspartate Aminotransferase Increased: 2 people, 10.00%
Drug Toxicity: 2 people, 10.00%
Dermatitis Medicamentosa (an irritation of the scrotum caused by an allergic reaction to a drug): 2 people, 10.00%
Liver Function Tests Nos Abnormal: 2 people, 10.00%
Completed Suicide (act of taking one's own life): 2 people, 10.00%
Alanine Aminotransferase Increased: 2 people, 10.00%
Anuria (failure of the kidneys to produce urine): 1 person, 5.00%
Clear Cell Carcinoma Of The Kidney (cancer of clear cell of kidney): 1 person, 5.00%

What are the existing conditions these people have? *

Urination - Painful: 2 people, 10.00%
Suicide Attempt: 2 people, 10.00%
Type 2 Diabetes: 1 person, 5.00%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 1 person, 5.00%
Joint Pain: 1 person, 5.00%
Indigestion: 1 person, 5.00%
Gastritis (inflammation of stomach): 1 person, 5.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.00%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Noroxin and have Hepatocellular damage?

- Check whether Hepatocellular damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Noroxin:

Noroxin (1,675 reports)

Browse all side effects of Noroxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatocellular damage:

Hepatocellular damage (503 drugs)

Browse all the conditions that are associated with Hepatocellular damage:

Hepatocellular damage (610 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on norfloxacin (the active ingredients of Noroxin) and Noroxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.